From: The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies
Study design | Differentially expressed proteins (gene abbreviations) | |||
---|---|---|---|---|
Human adipose tissue | ||||
Proteomics of 6 subcutaneous white adipose tissue depots (upper abdominal, lower abdominal, thigh, back, flank, and hip) of 6 female subjects [104] | Increased | Decreased | ||
HB (4 isoforms, back depot) | VIM (3 isoforms depot specific) | ENO1 (flank depot) | HPX (lower versus upper abdominal depot) | |
ALB (3 isoforms, hip depot) | ATP5B (hip, flank and upper abdominal depots) | HSP 8 (upper abdominal depot, superficial layer) | Â | |
HSP-β6 (hip depot, superficial layer) | HSP-60 kDa (hip depot) | SOD (flank depot) | ||
FABP-4 (2 isoforms, depot and isoform specific increases and decreases) | ||||
White adipose tissue C57BL/6J mice | ||||
White adipose tissue (inguinal, retroperitoneal, mesenteric and epididymal) proteomics of 6 male mice analyzed at 12 and 24Â months old [105] | Increased at 24 months | Decreased at 24 months | ||
ATP5B | ENO1 (2 isoforms) | CA-III (2 isoforms) | ANXA5 | |
PDHE1-B | IDH3α | ALB | HBB (2 isoforms) | |
E-FABP | CuZn-SOD | INS | HMW adiponectin | |
ERP29 | PPIA | Total adiponectin | Â | |
APOA4 | APOA1 (4 isoforms, 2 depot specific increases) | Â | Â | |
VIM | Â | Â | ||
ACT | Â | Â |